Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma
Copyright 2000 S. Karger AG, Basel.
We investigated micrometastasis in lymph nodes by detecting carcinoembryonic antigen (CEA) mRNA. A total of 400 lymph nodes obtained from 21 patients with esophageal carcinoma were examined by CEA-specific reverse transcription-polymerase chain reaction (RT-PCR). Serial sections of positive lymph nodes were reexamined histologically and immunohistologically. Twenty-seven lymph nodes of 11 patients were diagnosed as being positive by conventional histologic examination. CEA-mRNA positivity was found in 18 of 21 patients. Among 373 histologically negative nodes, 79 (21.2%) were positive for CEA mRNA. Of these, micrometastasis was detected in 2 by histological reexamination and in 11 by immunohistochemical staining using cytokeratin antibody. Two of 6 RT-PCR-positive patients (33.3%) had recurrent disease. Four of 11 patients (36.4%) whose nodal involvement was discovered by routine histological examination also had recurrent cancer. CEA-specific RT-PCR detected micrometastasis in lymph nodes at a higher rate than histological or immunohistochemical analysis of serial sections. Since the incidence of CEA-mRNA positivity is high in the lymph nodes of esophageal cancer patients except for those with early cancer, these patients should be treated with adjuvant therapy.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2000 |
---|---|
Erschienen: |
2000 |
Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
---|---|
Enthalten in: |
Oncology - 58(2000), 1 vom: 28., Seite 38-44 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kijima, F [VerfasserIn] |
---|
Themen: |
63231-63-0 |
---|
Anmerkungen: |
Date Completed 01.03.2000 Date Revised 01.11.2017 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM105739065 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM105739065 | ||
003 | DE-627 | ||
005 | 20231222135317.0 | ||
007 | tu | ||
008 | 231222s2000 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0353.xml |
035 | |a (DE-627)NLM105739065 | ||
035 | |a (NLM)10644939 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kijima, F |e verfasserin |4 aut | |
245 | 1 | 0 | |a Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma |
264 | 1 | |c 2000 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 01.03.2000 | ||
500 | |a Date Revised 01.11.2017 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright 2000 S. Karger AG, Basel | ||
520 | |a We investigated micrometastasis in lymph nodes by detecting carcinoembryonic antigen (CEA) mRNA. A total of 400 lymph nodes obtained from 21 patients with esophageal carcinoma were examined by CEA-specific reverse transcription-polymerase chain reaction (RT-PCR). Serial sections of positive lymph nodes were reexamined histologically and immunohistologically. Twenty-seven lymph nodes of 11 patients were diagnosed as being positive by conventional histologic examination. CEA-mRNA positivity was found in 18 of 21 patients. Among 373 histologically negative nodes, 79 (21.2%) were positive for CEA mRNA. Of these, micrometastasis was detected in 2 by histological reexamination and in 11 by immunohistochemical staining using cytokeratin antibody. Two of 6 RT-PCR-positive patients (33.3%) had recurrent disease. Four of 11 patients (36.4%) whose nodal involvement was discovered by routine histological examination also had recurrent cancer. CEA-specific RT-PCR detected micrometastasis in lymph nodes at a higher rate than histological or immunohistochemical analysis of serial sections. Since the incidence of CEA-mRNA positivity is high in the lymph nodes of esophageal cancer patients except for those with early cancer, these patients should be treated with adjuvant therapy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Carcinoembryonic Antigen |2 NLM | |
650 | 7 | |a DNA, Complementary |2 NLM | |
650 | 7 | |a RNA primers |2 NLM | |
650 | 7 | |a RNA, Messenger |2 NLM | |
650 | 7 | |a RNA |2 NLM | |
650 | 7 | |a 63231-63-0 |2 NLM | |
700 | 1 | |a Natsugoe, S |e verfasserin |4 aut | |
700 | 1 | |a Takao, S |e verfasserin |4 aut | |
700 | 1 | |a Aridome, K |e verfasserin |4 aut | |
700 | 1 | |a Baba, M |e verfasserin |4 aut | |
700 | 1 | |a Yoshifumi, M |e verfasserin |4 aut | |
700 | 1 | |a Eizuru, Y |e verfasserin |4 aut | |
700 | 1 | |a Aikou, T |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Oncology |d 1966 |g 58(2000), 1 vom: 28., Seite 38-44 |w (DE-627)NLM000043451 |x 1423-0232 |7 nnns |
773 | 1 | 8 | |g volume:58 |g year:2000 |g number:1 |g day:28 |g pages:38-44 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 58 |j 2000 |e 1 |b 28 |h 38-44 |